Mayne Pharma Group Ltd (MYX) — Capital Reinvestment Ratio
Mayne Pharma Group Ltd (MYX) has a Capital Reinvestment Ratio of 0.17x as of June 2025, meaning it reinvests 0% of its operating cash flow (AU$31.98 Million) in capital expenditures (AU$5.40 Million). See MYX equity to assets ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Mayne Pharma Group Ltd Capital Reinvestment Ratio (2010–2025)
This chart tracks Mayne Pharma Group Ltd's Capital Reinvestment Ratio across 12 annual periods. Check how aggressively does Mayne Pharma Group Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Mayne Pharma Group Ltd (2010–2025)
Year-by-year Capital Reinvestment Ratio for Mayne Pharma Group Ltd from 2010 to 2025. For live market cap and broader valuation context, see market cap of Mayne Pharma Group Ltd.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.70x | AU$17.47 Million | AU$12.28 Million | ▲ +32.3% |
| 2021 | 0.53x | AU$47.26 Million | AU$25.10 Million | ▲ +12.5% |
| 2020 | 0.47x | AU$99.78 Million | AU$47.12 Million | ▲ +322.6% |
| 2019 | 0.11x | AU$106.61 Million | AU$11.91 Million | ▼ -74.9% |
| 2018 | 0.45x | AU$121.50 Million | AU$54.18 Million | ▼ -19.4% |
| 2016 | 0.55x | AU$53.50 Million | AU$29.59 Million | ▲ +197.1% |
| 2015 | 0.19x | AU$22.42 Million | AU$4.17 Million | ▲ +15.8% |
| 2014 | 0.16x | AU$26.14 Million | AU$4.20 Million | ▼ -94.8% |
| 2013 | 3.08x | AU$6.84 Million | AU$21.06 Million | ▲ +1517.0% |
| 2012 | 0.19x | AU$13.39 Million | AU$2.55 Million | ▼ -63.1% |
| 2011 | 0.51x | AU$4.09 Million | AU$2.10 Million | ▲ +1225.0% |
| 2010 | 0.04x | AU$10.26 Million | AU$398.56K | — |